中国人群中特兰克萨姆酸的人口药理动力学 接受心脏手术的心肺绕道患者
Yue Liu1, Chenghui Zhou2, Hong Lv1
1Department of Anesthesiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Drug design, development and therapy
|June 2, 2025
概括
这项研究开发了中国心脏手术患者中第一个特兰胺酸 (TXA) 的人口药理动力学模型. 该模型有助于个性化TXA剂量,以改善患者的治疗结果.
科学领域:
- 药理动力学 药理动力学
- 药理学 药理学是指药理学的学科.
- 心血管外科心血管外科
背景情况:
- 种群药动力学 (PK) 模型对于个性化药物剂量至关重要.
- 对于中国人群,之前没有对特兰胺酸 (TXA) 的PK研究.
- 心脏手术患者需要优化TXA的管理.
研究的目的:
- 在接受心脏手术的中国患者中建立TXA的人口PK模型.
- 为个性化TXA剂量策略提供基础.
- 在这个特定的人口群体中评估TXA的PK.
主要方法:
- 一项涉及中国心脏手术患者的前性研究.
- 随机分配给高剂量 (30毫克/公斤玻尿酸,16毫克/公斤/小时维护) 或低剂量 (10毫克/公斤玻尿酸,2毫克/公斤/小时维护) TXA.
- 用LC-MS/MS在14个时间点测量血TXA度,并使用Phoenix NLME 8.3软件进行分析.
主要成果:
- 体重被确定为影响TXA PK的主要共同变量.
- 心肺绕道 (CPB) 并没有显著影响TXA PK.
- 人口PK参数 (CL1,V1,CL2,V2) 估计为70公斤的个体.
结论:
- 这项研究介绍了中国心脏手术患者中TXA的第一个人群PK模型.
- 开发的模型可以指导个性化的TXA管理.
- 目标控制输注 (TCI) 是优化TXA输送的一种潜在方法.
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
34
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
34
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
84
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
84
01:20Compartment Models: Two-Compartment Model
6.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
6.1K
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
203
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
203